4:38 PM ET
8-K
Leadership Change
OS Therapies Leadership Change
OS Therapies appointed Frank Knuettel II as Chief Financial Officer and Kerry Clem as Chief Commercial Officer, effective September 29, 2026. Mr. Knuettel succeeds Christopher P. Acevedo, who will transition to a consulting role, while Mr. Clem will lead the commercialization strategy for the company's lead product candidate, Herlystic.
- Term
- 3 years